An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver transplantation in Latin America. Treatment of hepatitis C infected patients improves important long-term outcomes as mortality. Sustained viral response is reached in near 50% of patients with the previous m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chávez Tapia, Norberto C., Ridruejo, Ezequiel, De Mattos, Angelo Alves, Bessone, Fernando, Daruich, Jorge, Sánchez Ávila, Juan F., Cheinquer, Hugo, Zapata, Rodrigo, Uribe Esquivel, Misael, Bosques Padilla, Francisco Javier, Gadano, Adrián, Soza, Alejandro, Dávalos Moscol, Milagros, Marroni, Claudio, Muñoz Espinoza, Linda, Castro Narro, Graciela, Paraná, Raymundo, Méndez Sánchez, Nahum
Formato:	Artículo
Lenguaje:	English
Publicado:	2013
Materias:	RC Medicina Interna, Psiquiatría, Neurología
Acceso en línea:	http://eprints.uanl.mx/23451/1/23451.pdf

An update on the management of hepatitis C: guidelines for protease inhibitor-based triple therapy from the Latin American Association for the Study of the Liver

Ejemplares similares